References
- SiegelRL, MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
- PalumboA, AndersonK. Multiple myeloma. New Engl J Med. 2011;364(11):1046-1060.
- PalumboA, BringhenS, LudwigH, et al. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood. 2011; 118(17): 4519-4529.
- ShahUA, MailankodyS. Emerging immunotherapies in multiple myeloma. BMJ. 2020;370.
- KumarSJ, CallanderNS, AdekoleA, AndersonL, et al. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. JNCCN. 2020;18(12). doi.org/10.6004/jnccn.2020.0057.